Literature DB >> 7526957

Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites.

S D Glick1, J Raucci, S Wang, R W Keller, J N Carlson.   

Abstract

Using in vivo microdialysis, this study attempted to determine whether a neurochemical predisposition to self-administer cocaine could be identified. Estimated extracellular levels of dopamine and its metabolites were measured bilaterally in the mesocorticolimbic and nigrostriatal systems of naive rats that were subsequently trained to self-administer cocaine intravenously. There were several significant relationships between dopamine and dopamine metabolite (3,4-dihydroxyphenylacetic acid and homovanillic acid) levels and rates of cocaine self-administration during both acquisition and asymptotic phases of testing. Dopamine levels in the nucleus accumbens were non-monotonically related to rates of self-administration during both phases: low to moderate dopamine levels were positively correlated with self-administration rates whereas moderate to high dopamine levels were negative correlated with self-administration rates. Dopamine, DOPAC (3,4-dihydroxyphenylacetic acid) and HVA (homovanillic acid) levels in the striatum were inversely correlated with self-administration rates during the acquisition phase. DOPAC and HVA levels in the left and right sides of the medial prefrontal cortex were positively and negatively correlated, respectively, with self-administration rates during the asymptotic phase; left/right asymmetrics in cortical metabolite levels were also correlated with asymptotic rates. There were no significant relationships between any neurochemical indices and rates of bar-pressing for water. These results suggest that the normal variability in drug seeking behavior is at least in part attributable to individual differences in the activity of brain dopamine systems.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526957     DOI: 10.1016/0006-8993(94)90383-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

2.  Nicotine self-administration in rats.

Authors:  E C Donny; A R Caggiula; S Knopf; C Brown
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

3.  Hemispheric Asymmetry of Development Due to Drug Exposure.

Authors:  Harold W Gordon
Journal:  J Syst Integr Neurosci       Date:  2017-04-29

Review 4.  Animal models of substance abuse and addiction: implications for science, animal welfare, and society.

Authors:  Wendy J Lynch; Katherine L Nicholson; Mario E Dance; Richard W Morgan; Patricia L Foley
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

5.  Perinatal distress leads to lateralized medial prefrontal cortical dopamine hypofunction in adult rats.

Authors:  W G Brake; R M Sullivan; A Gratton
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

6.  Individual differences in dopamine uptake in the dorsomedial striatum prior to cocaine exposure predict motivation for cocaine in male rats.

Authors:  Jessica K Shaw; I Pamela Alonso; Stacia I Lewandowski; Marion O Scott; Bethan M O'Connor; Shaili Aggarwal; Mariella De Biasi; Ole V Mortensen; Rodrigo A España
Journal:  Neuropsychopharmacology       Date:  2021-05-05       Impact factor: 8.294

7.  Sleep Deprivation Enhances Cocaine Conditioned Place Preference in an Orexin Receptor-Modulated Manner.

Authors:  Theresa E Bjorness; Robert W Greene
Journal:  eNeuro       Date:  2020-11-05

8.  Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement.

Authors:  R B Whitelaw; A Markou; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.